Evidence map›Paper›PMID 37252973›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2023

Dengue virus NS5 degrades ERC1 during infection to antagonize NF-kB activation.

María Mora Gonzalez Lopez Ledesma, Guadalupe Costa Navarro, Horacio M Pallares, Ana Paletta, Federico De Maio, Nestor G Iglesias, Leopoldo Gebhard, Santiago Oviedo Rouco, Diego S Ojeda, Luana de Borba and 6 more

Open access · greenAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
9.3field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 32 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Cellular Biology: Virus-Host Interactions and RNA Structure and Function.Current topics in microbiology and immunology · 2026
    Review
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Zika virus NS5 protein inhibits type I interferon signaling via CRL3 E3 ubiquitin ligase-mediated degradation of STAT2.Proceedings of the National Academy of Sciences of the United States of America · 2024
    Article
  19. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 6 institutions in 2 countries.

María Mora Gonzalez Lopez LedesmaFundación Instituto Leloir-CONICET, Buenos Aires C1405, Argentina.ORCID 0000-0002-2189-8388
Guadalupe Costa NavarroFundación Instituto Leloir-CONICET, Buenos Aires C1405, Argentina.
Horacio M PallaresFundación Instituto Leloir-CONICET, Buenos Aires C1405, Argentina.ORCID 0000-0002-2019-8574
Ana PalettaInstituto de Investigaciones Biomédicas en Retrovirus y SIDA, Universidad de Buenos Aires-National Scientific and Technical Research Council, Buenos Aires C1121, Argentina.
Federico De MaioFundación Instituto Leloir-CONICET, Buenos Aires C1405, Argentina.ORCID 0000-0001-7904-402X
Nestor G IglesiasFundación Instituto Leloir-CONICET, Buenos Aires C1405, Argentina.
Leopoldo GebhardFundación Instituto Leloir-CONICET, Buenos Aires C1405, Argentina.
Santiago Oviedo RoucoFundación Instituto Leloir-CONICET, Buenos Aires C1405, Argentina.
Diego S OjedaFundación Instituto Leloir-CONICET, Buenos Aires C1405, Argentina.
Luana de BorbaFundación Instituto Leloir-CONICET, Buenos Aires C1405, Argentina.ORCID 0009-0007-5918-0156
María GiraldoDepartment of Microbiology and Immunology, University of Texas Medical Branch, Galveston, TX 77555.
Ricardo RajsbaumDepartment of Medicine, Center for Virus-Host-Innate-Immunity, Rutgers Biomedical and Health Sciences, Newark, NJ 07101.ORCID 0000-0002-5058-5444
Ana CeballosInstituto de Investigaciones Biomédicas en Retrovirus y SIDA, Universidad de Buenos Aires-National Scientific and Technical Research Council, Buenos Aires C1121, Argentina.ORCID 0000-0003-4564-7361
Nevan J KroganUniversity of California, San Francisco, CA 94158.
Priya S ShahDepartment of Microbiology and Molecular Genetics, University of California, Davis, CA 95616.
Andrea V GamarnikFundación Instituto Leloir-CONICET, Buenos Aires C1405, Argentina.
Consejo Nacional de Investigaciones Científicas y Técnicas · ARUniversidad de Buenos Aires · ARRutgers, The State University of New Jersey · USThe University of Texas Medical Branch at Galveston · USUniversity of California, Davis · USUniversity of California, San Francisco · US

Funding

Viral Immunity and VAccination (VIVA) Human Immunology Project Consortium (HIPC)U19AI168631 · NIAID · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI Ana Fernandez-Sesma · 2022 to 2026
$14.4M
Research Project 3: Role of Posttranslational Protein Modifications in the Pathogenesis of Ebola Virus DiseaseP01AI150585 · NIAID · UNIVERSITY OF TEXAS MED BR GALVESTON · PI BUKREYEV, ALEXANDER · 2021 to 2025
$11.3M
UTMB WOMEN'S HEALTH RESEARCH SCHOLARS PROGRAMK12HD052023 · NICHD · UNIVERSITY OF TEXAS MEDICAL BR GALVESTON · PI BERENSON, ABBEY B · 2005 to 2023
$8.1M
Regulation of Ebola virus replication by the host ubiquitin systemR01AI134907 · NIAID · UNIVERSITY OF TEXAS MED BR GALVESTON · PI GIRALDO, MARIA ISABEL · 2018 to 2022
$3.1M
The Role of the Host Ubiquitin System in Promoting SARS-CoV-2 Replication and PathogenesisR01AI166668 · NIAID · UNIVERSITY OF TEXAS MED BR GALVESTON · PI RAJSBAUM, RICARDO · 2021 to 2025
$2.6M
The Role of TRIM6 and Ubiquitin in Influenza Virus-Induced PathologyR01AI155466 · NIAID · UNIVERSITY OF TEXAS MED BR GALVESTON · PI Ricardo Rajsbaum · 2021 to 2026
$2.5M
MECHANISMS OF DENGUE VIRUS GENOME ENCAPSIDATION AND UNCOATINGR01AI095175 · NIAID · FUNDACION INSTITUTO LELOIR · PI GAMARNIK, ANDREA · 2011 to 2020
$1.0M
NIAID NIH HHS P01 AI150585NIAID NIH HHS R01 AI095175NIAID NIH HHS R01 AI134907NIAID NIH HHS R01 AI155466NIAID NIH HHS R01 AI166668NIAID NIH HHS U19 AI168631NICHD NIH HHS K12 HD052023
6 · The paper itself

Abstract

Dengue virus (DENV) is the most important human virus transmitted by mosquitos. Dengue pathogenesis is characterized by a large induction of proinflammatory cytokines. This cytokine induction varies among the four DENV serotypes (DENV1 to 4) and poses a challenge for live DENV vaccine design. Here, we identify a viral mechanism to limit NF-κB activation and cytokine secretion by the DENV protein NS5. Using proteomics, we found that NS5 binds and degrades the host protein ERC1 to antagonize NF-κB activation, limit proinflammatory cytokine secretion, and reduce cell migration. We found that ERC1 degradation involves unique properties of the methyltransferase domain of NS5 that are not conserved among the four DENV serotypes. By obtaining chimeric DENV2 and DENV4 viruses, we map the residues in NS5 for ERC1 degradation, and generate recombinant DENVs exchanging serotype properties by single amino acid substitutions. This work uncovers a function of the viral protein NS5 to limit cytokine production, critical to dengue pathogenesis. Importantly, the information provided about the serotype-specific mechanism for counteracting the antiviral response can be applied to improve live attenuated vaccines.

Indexed as

DengueDengue VirusViral Nonstructural ProteinsAdaptor Proteins, Signal TransducingCytokinesHumansNerve Tissue ProteinsNF-kappa BSerogroupAdaptor Proteins, Signal TransducingCytokinesERC1 protein, humanNerve Tissue ProteinsNF-kappa BNS5 protein, dengue virusViral Nonstructural Proteinsdengue virusdengue virus pathogenesisevasion of innate antiviral responseshost–virus interactionsNS5 viral protein activation

Identifiers

PMID37252973
PMCPMC10266027
OpenAlexW4378782309

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.